Evidence map›Paper›PMID 39209958›Full record

ReviewInternational journal of impotence research2025

Perspective: Clinical care of pedophilic individuals in Zurich, Switzerland.

Fanny de Tribolet-Hardy, Simon Veitz, Laura Dittli, Elmar Habermeyer

Abstract readReview
In one paragraph

Review in International journal of impotence research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Paraphilias-where do we go from here?International journal of impotence research · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Fanny de Tribolet-HardyUniversity of Zurich, Department of Forensic Psychiatry, University Hospital of Psychiatry Zurich, Zurich, Switzerland. fanny.detribolet@pukzh.ch.ORCID http://orcid.org/0009-0002-2695-9810
Simon VeitzUniversity of Zurich, Department of Forensic Psychiatry, University Hospital of Psychiatry Zurich, Zurich, Switzerland.
Laura DittliUniversity of Zurich, Department of Forensic Psychiatry, University Hospital of Psychiatry Zurich, Zurich, Switzerland.
Elmar HabermeyerUniversity of Zurich, Department of Forensic Psychiatry, University Hospital of Psychiatry Zurich, Zurich, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Individuals with pedophilia are considered to have an elevated risk for child sexual abuse (CSA). Nevertheless, it is assumed that pedophilic sexual impulses can be controlled from acting out. To prevent CSA an outpatient treatment facility for people with pedophilia was founded in Zurich, Switzerland in 2021. The program focuses on the prevention of CSA and improvement of quality of life, incorporating empirically validated treatment principles, such as the Risk-Need-Responsivity (RNR) model and the Good Lives Model (GLM). Within the initial 24-month 142 individuals sought help, 46 individuals (mean age 36.0 ± 12.4 years) completed the assessment phase, two-thirds suffered from psychiatric comorbidities, and 67.4% reported sexual delinquency. The high drop-out rate was predominantly due to ongoing criminal proceedings, or other mental health conditions. Overall patients at this facility generally sought treatment voluntarily, leading to good treatment adherence, with severe self-harm being more prevalent than acute danger to others. A treatment approach focused solely on pedophilia is considered insufficient; psychiatric and psychosocial factors must also be addressed.

Indexed as

Child Abuse, SexualPedophiliaAdultChildFemaleHumansMaleMiddle AgedQuality of LifeSwitzerland

Identifiers

PMID39209958
PMCPMC11981926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.